Knowledge Distillery

To circumvent time-consuming clinical trials, testing whether existing drugs are effective inhibitors of SARS-CoV-2 , has led to the discovery of…

Control of the global COVID-19 pandemic will require the development and deployment of safe and effective vaccines.

The objective of this prospective uncontrolled cohort study was to describe the consequences at 4 months in patients hospitalized for COVID-19.

Extensive global sampling and sequencing of the pandemic virus SARS-CoV-2 have enabled researchers to monitor its spread, and to identify concerning…

A novel SARS-CoV-2 variant, VOC 202012/01 (lineage B.1.1.7), emerged in southeast England in November 2020 and is rapidly spreading toward fixation.

Substitution for aspartic acid by glycine at position 614 in the spike (S) protein of severe acute respiratory syndrome coronavirus 2 appears to…

SARS-CoV-2 infections and hospital admissions for COVID-19 increased rapidly in the South East region of England in November and December 2020,…

The efficacy of two injections of the SARS-CoV-2 spike mRNA vaccines (BNT162b2 [Pfizer] and mRNA-1273 [Moderna]) in preventing symptomatic SARS-CoV-2…

As mass vaccination campaigns against COVID-19 commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse…

Assessment of the safety and efficacy of vaccines against the SARS-CoV-2 in different populations is essential, as is investigation of the efficacy…

Coronavirus disease have been reported to be associated with several neurological manifestations such as stroke, Guillain-Barré syndrome,…

The coronavirus spike glycoprotein, located on the virion surface, is the key mediator of cell entry and the focus for development of protective…